The brand printed on the label is less informative than the documentation available for the product inside the vial
Cardiovascular Risk Reduction: Beyond Weight and Diabetes The LEADER, SUSTAIN-6, and REWIND trials established that GLP-1 agonists reduce major adverse cardiovascular events in patients with established heart disease or multiple risk factors
To help keep Wegovy at the right temperature while on the road, consider storing it in a thermal or insulated case or cooler
Injection Techniques: Local vs
It is available in both injectable forms and as oral semaglutide, offering a convenient alternative for those who prefer a pill over injections
What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care Brandon Aylward Oct 16, 2025 10 min read Few categories in modern medicine have captured the imagination of patients, physicians, and investors as quickly as GLP-1 receptor agonists (GLP-1s)